Non-systemic Intestine-Targeted Drugs
Author:
Publisher
Elsevier
Reference187 articles.
1. Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma;Eichler;Nat Rev Drug Discov,2008
2. Drug safety sciences and the bottleneck in drug development;Watkins;Clin Pharmacol Ther,2011
3. The determination and interpretation of the therapeutic index in drug development;Muller;Nat Rev Drug Discov,2012
4. The utility of in vitro cytochrome P450 inhibition data in the prediction of drug–drug interactions;Obach;J Pharmacol Exp Ther,2005
5. Mechanism-based inhibition of cytochrome P450 enzymes: an evaluation of early decision making in vitro approaches and drug–drug interaction prediction methods;Grime;Eur J Pharm Sci,2009
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Physiologically Based Biopharmaceutics Model (PBBM) of Minimally Absorbed Locally Acting Drugs in the Gastrointestinal Tract—Case Study: Tenapanor;Pharmaceutics;2023-12-04
2. Trust Your Gut: Strategies and Tactics for Intestinally Restricted Drugs;ACS Medicinal Chemistry Letters;2023-02-22
3. Design and exploration of gut-restricted bifunctional molecule with TGR5 agonistic and DPP4 inhibitory effects for treating ulcerative colitis;European Journal of Medicinal Chemistry;2022-11
4. Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders;Frontiers in Pharmacology;2022-10-25
5. Design and Exploration of Gut-Restricted Bifunctional Molecule with TGR5 Agonistic and DPP4 Inhibitory Effects for Treating Ulcerative Colitis;SSRN Electronic Journal;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3